Oncology · Precision Cancer Testing

BRCAssure
Complete BRCA1 & BRCA2 gene Analysis

Comprehensive hereditary and somatic BRCA testing supporting cancer risk assessment and PARP inhibitor therapy.

Blood or FFPE
Sample Type
1 FFPE block or 10–15 slides
Samples
~14 working days
Turnaround Time

BRCAssure at Nucleome Informatics

Complete BRCA1 & BRCA2 gene Analysis

Why this Test Matters

Precision oncology depends on identifying clinically actionable genomic alterations. This assay helps clinicians select targeted therapies, evaluate immunotherapy eligibility, identify prognostic biomarkers, detect resistance mechanisms, and match patients to suitable clinical trials while minimizing sequential testing.

Who Should Consider this Test

  • Breast
  • Ovarian
  • Pancreatic
  • Prostate cancer
  • Strong family history

Applicable Cancer Types

Breast, Ovarian, Pancreatic, Prostate

What the test covers and delivers

What is Covered

  • Complete BRCA1/2
  • SNVs
  • InDels
  • Large deletions
  • Duplications

Clinical Utility​

  • Treatment selection
  • Prognostic and predictive biomarkers
  • Clinical trial matching
  • Identification of actionable alterations
  • Comprehensive clinical interpretation

Technology

High-depth sequencing with CNV analysis

Test specifications

ParameterDetails
Sample TypeBlood or FFPE
Samples1 FFPE block or 10–15 slides
Turnaround Time~14 working days
Report IncludesVariant interpretation, therapy associations, clinically actionable biomarkers
QualityHigh-depth NGS with rigorous QC
Talk to our team. Email info@nucleomeinfo.com or call +91 40 40114169 to discuss sample requirements and turnaround for BRCAssure.